Lomotil

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

Lomotil

Combination of
Diphenoxylate	mu opiate receptor agonist
Atropine	muscarinic acetylcholine receptors antagonist
[[{{{component3}}}]]	? Class
[[{{{component4}}}]]	? Class
[[{{{component5}}}]]	? Class
Clinical data
Routes of administration	Oral
Legal status
Legal status	UK: POM (Prescription only) US: Schedule V
Identifiers
E number	{{#property:P628}}
ECHA InfoCard	{{#property:P2566}}

WikiDoc Resources for Lomotil
Articles
Most recent articles on Lomotil Most cited articles on Lomotil Review articles on Lomotil Articles on Lomotil in N Eng J Med, Lancet, BMJ
Media
Powerpoint slides on Lomotil Images of Lomotil Photos of Lomotil Podcasts & MP3s on Lomotil Videos on Lomotil
Evidence Based Medicine
Cochrane Collaboration on Lomotil Bandolier on Lomotil TRIP on Lomotil
Clinical Trials
Ongoing Trials on Lomotil at Clinical Trials.gov Trial results on Lomotil Clinical Trials on Lomotil at Google
Guidelines / Policies / Govt
US National Guidelines Clearinghouse on Lomotil NICE Guidance on Lomotil NHS PRODIGY Guidance FDA on Lomotil CDC on Lomotil
Books
Books on Lomotil
News
Lomotil in the news Be alerted to news on Lomotil News trends on Lomotil
Commentary
Blogs on Lomotil
Definitions
Definitions of Lomotil
Patient Resources / Community
Patient resources on Lomotil Discussion groups on Lomotil Patient Handouts on Lomotil Directions to Hospitals Treating Lomotil Risk calculators and risk factors for Lomotil
Healthcare Provider Resources
Symptoms of Lomotil Causes & Risk Factors for Lomotil Diagnostic studies for Lomotil Treatment of Lomotil
Continuing Medical Education (CME)
CME Programs on Lomotil
International
Lomotil en Espanol Lomotil en Francais
Business
Lomotil in the Marketplace Patents on Lomotil
Experimental / Informatics
List of terms related to Lomotil

Lomotil is the trade name of a popular oral anti-diarrheal drug in the United States, manufactured by Pfizer. Its UK BAN generic name is Co-phenotrope.

Its active ingredients are diphenoxylate and atropine. Diphenoxylate is anti-diarrheal and atropine is anticholinergic. Diphenoxylate is chemically related to the narcotic drug meperidine. A subtherapeutic amount of atropine sulfate is present to discourage deliberate overdosage. Atropine has no anti-diarrheal properties, but will cause tachycardia when overused. The medication diphenoxylate works by slowing down the movement of the intestines.

The inactive ingredients of Lomotil (as a liquid - it comes in pill form as well) are cherry flavor, citric acid, ethyl alcohol 15%, FD&C Yellow No. 6, glycerin, sodium phosphate, sorbitol, and water.

Other trade names for the same therapeutic combination are Lofene, Logen, Lomanate and Lonox, among others. In other countries, Lomotil may have other names.

In the United States, Lomotil (Diphenoxylate HCl and atropine sulfate) is classified as a Schedule V controlled substance by federal law, and is available only for a medical purpose.

Contraindications

Absolute contraindications for Lomotil are:

• Allergy to diphenoxylate or atropine
• Presence of jaundice
• Diarrhea associated with pseudomembranous enterocolitis, diarrhea caused by antibiotic treatment, or diarrhea caused by enterotoxin-producing bacteria.

Interactions

Interactions with other drugs:

• Sedatives
• Barbiturates
• Antidepressants (e.g., Elavil, Prozac, Paxil)
• Tranquilizers (e.g., Valium, Xanax)
• Monoamine oxidase inhibitors (e.g., Nardil, Parnate)

Diarrhea that is caused by some antibiotics such as cefaclor, erythromycin or tetracycline can worsen with Lomotil.

Safety

The drug combination is generally safe in short-term use and with recommended dosage. Long-term use may present problems of mild drug dependency. The dosage should be reduced after 48 h.

Lomotil may cause several side-effects, such as dry mouth, headache, constipation and blurred vision. Since it may cause also drowsiness or dizziness, Lomotil should not be used by motorists, operators of hazardous machinery, etc. It is not recommended for children under two years of age. In rare cases lomotil may cause paresthesia.

Toxicity

Lomotil may cause serious health problems when overdosed. Signs and symptoms of adverse effects may include any or several of the following: convulsions, respiratory depression (slow or stopped breathing), pinpoint or dilated eye pupils, nystagmus (rapid side-to-side eye movements), erythema (flushed skin), gastrointestinal constipation, nausea, vomiting, paralytic ileus, tachycardia (rapid pulse), drowsiness, coma and hallucinations. Symptoms of toxicity may take up to 12 hours to appear.

Treatment of Lomotil overdose must be initiated immediately after diagnosis and may include the following: emesis (induced vomiting), gastric lavage, ingestion of activated charcoal, laxative and a counteracting medication (narcotic antagonist).

Prompt and thorough treatment of overdose leads to a favorable outcome. After a narcotic antagonist is given, recovery is usually within 24 to 48 hours. Children are at risk of a very poor outcome and must be kept for observation.

External links

• Diphenoxylate and Atropin. RxList.

Source

• Lomotil overdose. MedlinePlus Medical Encyclopedia. Public domain.